First GMP Warning Letter Reflects FDA's List Of Major Concerns
This article was originally published in The Tan Sheet
Executive Summary
FDA's first warning letter concerning dietary supplement good manufacturing practices advises Coats International Holdings to follow written procedures, improve documentation and conduct appropriate identity tests